The mortality rate in the CB group showed a decreasing trend over time, aligning with improvements in overall treatment strategies and critical care interventions (61.2% in 2012 to 46.2% in 2021 [ P trend <0.001]).
← all excerpts
Trends and outcomes of chemotherapy timing in critically ill patients with hematologic malignancies using a Japanese national database.
1
—
—